Skip to main content
Top
Published in: Medical Microbiology and Immunology 1/2012

01-02-2012 | Rapid Communication

High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue

Authors: Dieter Mitteregger, Stephan W. Aberle, Athanasios Makristathis, Julia Walochnik, Wolfgang Brozek, Michael Marberger, Gero Kramer

Published in: Medical Microbiology and Immunology | Issue 1/2012

Login to get access

Abstract

While Trichomonas vaginalis, a protozoan parasite, is a well-investigated pathogen in the female population, there is little awareness of its significance in the male uro-genital tract. The presence of T. vaginalis in the prostate gland has only been scarcely investigated and has never been attested in conditions other than clinical prostatitis. Still, by some authors, this organ is regarded as ecologic niche for T. vaginalis. Since normal prostate tissue of sufficient quality is hard to come by, we investigated samples from 86 patients (mean age 68.7 ± 7.6 years) suffering from benign prostatic hyperplasia (BPH), a medical condition currently ranked as noninfectious, but characterized by chronic inflammatory tissue infiltrates of unknown etiology. Applying two different PCR protocols and sequence analysis of the respective amplicons, we detected T. vaginalis DNA in 29/86 (34%) BPH tissue samples, whereas in only 2/86 (2.3%) cases T. vaginalis grew in culture. Detection of T. vaginalis DNA correlated significantly (P < 0.01) with elevated peripheral blood monocytic cell counts, appearing along with protozoan infections. Given the unexpected high prevalence of T. vaginalis in BPH tissue of a nonselected, elderly study population from Austria, further epidemiological studies have to confirm this finding. Potential interactions of T. vaginalis in its prostatic habitat may be investigated with respect to their possible contribution to the inflammatory pathogenesis of BPH, since inflammatory cytokines have been shown to sustain prostatic hyperplastic growth.
Literature
1.
go back to reference Petrin D, Delgaty K, Bhatt R, Garber G (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11(2):300–317PubMed Petrin D, Delgaty K, Bhatt R, Garber G (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11(2):300–317PubMed
2.
3.
go back to reference Walochnik J, Aspock H (2002) Trichomonas vaginalis—a parasitic pathogen being causative of a veneral disease (German). Denisia 6, cataloges of the Federal State Museum of Upper Austria 184:145–161 Walochnik J, Aspock H (2002) Trichomonas vaginalis—a parasitic pathogen being causative of a veneral disease (German). Denisia 6, cataloges of the Federal State Museum of Upper Austria 184:145–161
4.
go back to reference Gaydos CA, Maldeis N, Hardick A, Hardick J, Quinn TC (2009) Mycoplasma genitalium compared to Chlamydia, Gonorrhea, and Trichomonas as an etiologic agent of urethritis in men attending STD clinics. Sex Transm Infect 85(6):438–440 Gaydos CA, Maldeis N, Hardick A, Hardick J, Quinn TC (2009) Mycoplasma genitalium compared to Chlamydia, Gonorrhea, and Trichomonas as an etiologic agent of urethritis in men attending STD clinics. Sex Transm Infect 85(6):438–440
5.
go back to reference Schwebke JR, Hook 3rd EW (2003) High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 188(3):465–468PubMedCrossRef Schwebke JR, Hook 3rd EW (2003) High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 188(3):465–468PubMedCrossRef
6.
go back to reference Skerk V, Schonwald S, Krhen I, Markovinovic L, Beus A, Kuzmanovic NS, Kruzic V, Vince A (2002) Aetiology of chronic prostatitis. Int J Antimicrob Agents 19(6):471–474PubMedCrossRef Skerk V, Schonwald S, Krhen I, Markovinovic L, Beus A, Kuzmanovic NS, Kruzic V, Vince A (2002) Aetiology of chronic prostatitis. Int J Antimicrob Agents 19(6):471–474PubMedCrossRef
7.
go back to reference Krieger JN, Riley DE, Roberts MC, Berger RE (1996) Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 34(12):3120–3128PubMed Krieger JN, Riley DE, Roberts MC, Berger RE (1996) Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 34(12):3120–3128PubMed
8.
go back to reference Lee JC, Muller CH, Rothman I, Agnew KJ, Eschenbach D, Ciol MA, Turner JA, Berger RE (2003) Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 169(2):584–587 discussion 587–588PubMedCrossRef Lee JC, Muller CH, Rothman I, Agnew KJ, Eschenbach D, Ciol MA, Turner JA, Berger RE (2003) Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 169(2):584–587 discussion 587–588PubMedCrossRef
9.
go back to reference Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68(3):306–320PubMedCrossRef Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68(3):306–320PubMedCrossRef
10.
go back to reference Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC (2003) Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61(2):267PubMedCrossRef Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC (2003) Benign prostatic hyperplasia: a progressive disease of aging men. Urology 61(2):267PubMedCrossRef
11.
go back to reference Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97(Suppl 2):3–6 (discussion 21–22)PubMedCrossRef Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97(Suppl 2):3–6 (discussion 21–22)PubMedCrossRef
12.
go back to reference Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52(1):43–58PubMedCrossRef Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52(1):43–58PubMedCrossRef
13.
go back to reference Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, Paikl D, Ecker RC, Hrachowitz K, Kramer G, Lee C, Marberger M (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83(8):1131–1146PubMedCrossRef Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, Paikl D, Ecker RC, Hrachowitz K, Kramer G, Lee C, Marberger M (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83(8):1131–1146PubMedCrossRef
14.
go back to reference Roehrborn C, Kaplan S, Noble W, Lucia S, Slawin K, McVary K, Kusek J, Nyberg L Jr (2005) The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study. J Urol 173(Suppl 4):346 (Abstr.) Roehrborn C, Kaplan S, Noble W, Lucia S, Slawin K, McVary K, Kusek J, Nyberg L Jr (2005) The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study. J Urol 173(Suppl 4):346 (Abstr.)
15.
go back to reference Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, Motiwala HG, Laniado ME (2007) Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 100(2):327–331PubMedCrossRef Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, Motiwala HG, Laniado ME (2007) Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 100(2):327–331PubMedCrossRef
16.
go back to reference Lucia MS, Lambert JR (2008) Growth factors in benign prostatic hyperplasia: basic science implications. Curr Urol Rep 9(4):272–278PubMedCrossRef Lucia MS, Lambert JR (2008) Growth factors in benign prostatic hyperplasia: basic science implications. Curr Urol Rep 9(4):272–278PubMedCrossRef
17.
go back to reference Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5):1202–1216PubMedCrossRef Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5):1202–1216PubMedCrossRef
18.
go back to reference Diamond LS, Harlow DR, Cunnick CC (1978) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72(4):431–432PubMedCrossRef Diamond LS, Harlow DR, Cunnick CC (1978) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72(4):431–432PubMedCrossRef
19.
go back to reference Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA (1998) Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36(11):3205–3210PubMed Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA (1998) Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36(11):3205–3210PubMed
20.
go back to reference Kengne P, Veas F, Vidal N, Rey JL, Cuny G (1994) Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40(6):819–831PubMed Kengne P, Veas F, Vidal N, Rey JL, Cuny G (1994) Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) 40(6):819–831PubMed
21.
go back to reference Crucitti T, Van Dyck E, Tehe A, Abdellati S, Vuylsteke B, Buve A, Laga M (2003) Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 79(5):393–398PubMedCrossRef Crucitti T, Van Dyck E, Tehe A, Abdellati S, Vuylsteke B, Buve A, Laga M (2003) Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 79(5):393–398PubMedCrossRef
23.
go back to reference Cornbleet P, Astarita R, Wolf P (1991) White blood cell and platelet disorders. In: Howanitz J, Howanitz P (eds) Laboratory medicine, 1st edn. Churchill Livingstone, New York, Edinburgh, London, Melburne, Tokyo, p 554 Cornbleet P, Astarita R, Wolf P (1991) White blood cell and platelet disorders. In: Howanitz J, Howanitz P (eds) Laboratory medicine, 1st edn. Churchill Livingstone, New York, Edinburgh, London, Melburne, Tokyo, p 554
24.
go back to reference Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, Singh BN (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74(10):5773–5779PubMedCrossRef Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, Singh BN (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74(10):5773–5779PubMedCrossRef
25.
go back to reference Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M (2004) Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60(2):153–159PubMedCrossRef Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M (2004) Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60(2):153–159PubMedCrossRef
26.
go back to reference Giri D, Ittmann M (2001) Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159(1):139–147PubMedCrossRef Giri D, Ittmann M (2001) Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159(1):139–147PubMedCrossRef
Metadata
Title
High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue
Authors
Dieter Mitteregger
Stephan W. Aberle
Athanasios Makristathis
Julia Walochnik
Wolfgang Brozek
Michael Marberger
Gero Kramer
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 1/2012
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-011-0205-2

Other articles of this Issue 1/2012

Medical Microbiology and Immunology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine